SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The Vanguard Growth ETF ( VUG 0.85%) doesn't just beat the market -- it demolishes it. A $10,000 investment at its 2004 ...

Rashmika Mandanna’s upcoming film Mysaa shows her as a fierce warrior, and the powerful poster has stunned fans. Here are 5 ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Lilly King Gets One More Win at Indy Summer Cup; Regan Smith Drops 56.5 100 Fly Soon-to-be retired Lilly King got one more ...

The USWNT starts a three-game window Thursday with a friendly against the Republic of Ireland. Follow along for live updates ...

The Lilly Pulitzer brand is the epitome of beachy summer style, but at a cost. Not right now, though, since the brand's ...

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

Shares in biopharmaceutical company Viking Therapeutics (NASDAQ: VKTX) were up by 6.3% at 12:30 a.m. ET today. The move ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.